Stockscreener 앱 받기
63.27
0.60%
-0.38
시간 외 거래:
63.75
0.48
+0.76%
전일 마감가:
$63.65
열려 있는:
$63.175
하루 거래량:
1.41M
Relative Volume:
0.74
시가총액:
$7.47B
수익:
$1.40B
순이익/손실:
$316.89M
주가수익비율:
25.39
EPS:
2.4918
순현금흐름:
$644.59M
1주 성능:
-0.46%
1개월 성능:
-12.17%
6개월 성능:
-18.69%
1년 성능:
-1.60%
1일 변동 폭
$62.63
$64.37
1주일 범위
$62.63
$65.77
52주 변동 폭
$47.50
$82.22
Halozyme Therapeutics Inc Stock (HALO) Company Profile
명칭
Halozyme Therapeutics Inc
전화
(858) 794-8889
주소
12390 EL CAMINO REAL, SAN DIEGO, CA
Compare HALO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HALO
Halozyme Therapeutics Inc
|
63.27 | 7.51B | 1.40B | 316.89M | 644.59M | 2.4918 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-10-14 | 업그레이드 | Leerink Partners | Underperform → Market Perform |
| 2025-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-05-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 다운그레이드 | Leerink Partners | Market Perform → Underperform |
| 2024-10-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-09-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-06-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-02-29 | 개시 | TD Cowen | Outperform |
| 2023-07-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-24 | 개시 | H.C. Wainwright | Buy |
| 2023-05-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-03-27 | 재개 | Berenberg | Buy |
| 2023-03-16 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
| 2022-12-21 | 재개 | Morgan Stanley | Overweight |
| 2022-11-28 | 개시 | Wells Fargo | Overweight |
| 2022-09-09 | 개시 | Morgan Stanley | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-06-14 | 개시 | Evercore ISI | Outperform |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-21 | 재확인 | The Benchmark Company | Buy |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-07-01 | 개시 | The Benchmark Company | Buy |
| 2020-02-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-01-09 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2020-01-08 | 개시 | Goldman | Buy |
| 2019-11-05 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-10-19 | 재개 | Piper Jaffray | Neutral |
| 2018-05-11 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-16 | 재확인 | Piper Jaffray | Overweight |
| 2017-01-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2016-11-03 | 개시 | Deutsche Bank | Buy |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-11-18 | 개시 | Citigroup | Buy |
| 2015-09-22 | 개시 | Barclays | Overweight |
| 2015-06-22 | 재확인 | JP Morgan | Overweight |
| 2015-03-03 | 재확인 | UBS | Buy |
| 2015-02-18 | 재확인 | MLV & Co | Buy |
| 2015-01-08 | 재확인 | MLV & Co | Buy |
모두보기
Halozyme Therapeutics Inc 주식(HALO)의 최신 뉴스
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 - GlobeNewswire Inc.
Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report? - Yahoo Finance Singapore
Halozyme Therapeutics : ESG Key Data & Metrics (rev11 Halozyme ESG Key Data 2026 ISS Corporate comments Mar2026 version 1 for publication) - marketscreener.com
Halozyme (HALO) loses 9% on weak earnings - MSN
Halozyme declines after Q4 bottom line miss, reiterates 2026 guidance - MSN
Halozyme Therapeutics Touts $1.8B Revenue Outlook, ENHANZE Royalties and New Hypercon Deals at Conference - Yahoo Finance
Alliancebernstein Reduces Stake in Halozyme Therapeutics - National Today
Alliancebernstein L.P. Trims Stake in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Could Halozyme (HALO) Returning David Ramsay as Interim CFO Reframe Its ENHANZE Royalty Story? - simplywall.st
Growth Value: Is Halozyme Therapeutics Inc forming a bullish divergenceWeekly Trend Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Halozyme Therapeutics, Inc. $HALO Shares Acquired by Clark Capital Management Group Inc. - MarketBeat
Brevan Howard Sells Stake in Halozyme Therapeutics - National Today
Brevan Howard Capital Management LP Sells 96,806 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Aquatic Capital Management Buys Stake in Halozyme Therapeutics - National Today
Aquatic Capital Management LLC Acquires Shares of 89,651 Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme appoints David Ramsay as interim CFO - MSN
Halozyme Therapeutics, Inc. $HALO Shares Bought by ArrowMark Colorado Holdings LLC - MarketBeat
Halozyme names David Ramsay as interim CFO - Investing.com Nigeria
Halozyme Therapeutics (HALO) Valuation Check After Recent Share Price Pullback - Sahm
Is Halozyme Therapeutics (HALO) Pricing Look Interesting After Recent Share Price Volatility - simplywall.st
Halozyme Therapeutics Receives 'Hold' Rating from Analysts - National Today
2Xideas AG Trims Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Halozyme Names Interim CFO As Investors Weigh Valuation And Recent Weakness - Yahoo Finance
Kennedy Capital Management LLC Reduces Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme names David Ramsay as interim CFO By Investing.com - Investing.com India
Halozyme Taps David Ramsay as Interim Chief Financial Officer - Contract Pharma
Is Halozyme Therapeutics a Better Buy Than United Therapeutics? - Trefis
Halozyme Names David Ramsay Interim Chief Financial Officer - TipRanks
Halozyme Therapeutics, Inc. Appoints David Ramsay as Interim Chief Financial Officer, Effective March 23, 2026 - marketscreener.com
Halozyme (HALO) Appoints David Ramsay as Interim CFO - GuruFocus
Halozyme (HALO) Appoints Interim CFO Amid Search for Permanent E - GuruFocus
David Ramsay returns as interim CFO at Halozyme (HALO) - Stock Titan
Halozyme Appoints David Ramsay as Interim Chief Financial Officer - marketscreener.com
Capital Fund Management Boosts Stake in Halozyme Therapeutics - National Today
Capital Fund Management S.A. Has $15.60 Million Stake in Halozyme Therapeutics, Inc. $HALO - MarketBeat
HALO Stock Price, Quote & Chart | HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - ChartMill
Halozyme Therapeutics (HALO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Halozyme at Citizens Life Sciences: Strategic Growth and Innovations By Investing.com - Investing.com Nigeria
Halozyme at Citizens Life Sciences: Strategic Growth and Innovations - Investing.com
Insider Selling: Cortney Caudill Unloads $1.96M Of Halozyme Therapeutics Stock - Benzinga
Halozyme Therapeutics, Inc. $HALO Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
Halozyme Therapeutics COO Sells $599,000 in Shares - National Today
Halozyme Therapeutics (NASDAQ:HALO) COO Cortney Caudill Sells 8,857 Shares - MarketBeat
Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) COO Sells 20,000 Shares of Stock - MarketBeat
Halozyme at Leerink Conference: Strategic Advances in Drug Delivery By Investing.com - Investing.com Canada
Halozyme Therapeutics COO Cortney Caudill Sells Shares - TradingView
Halozyme at Leerink Conference: Strategic Advances in Drug Delivery - Investing.com
Halozyme (HALO) COO exercises 21,546 options and sells 28,857 shares - Stock Titan
HALO (NASDAQ: HALO) insider sale notice — 20,000 shares on 03/09/2026 - Stock Titan
Rule 144 sale notice: HALO (NASDAQ: HALO) 20,000 shares via option exercise - Stock Titan
Halozyme Therapeutics Inc (HALO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):